Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Venus Remedies Ltd.

Price on BSE   02 Mar,15:29 LIVE
650.50
-21.65
(-3.22%)

© 2026 Rediff.com
  • Volume :
  • 1,588.00
  • Prev Close :
  • 672.15
  • Day's H/L (Rs.) :
  • 670.00 - 642.00
  • 52wk H/L (Rs.) :
  • 872.80 - 277.85
  • Mkt Cap (Rs. Cr) :
  • 871.68
Price on NSE   02 Mar,15:40 LIVE
651.45
-20.95
(-3.12%)

© 2026 Rediff.com
  • Volume :
  • 57,695.00
  • Prev Close :
  • 672.40
  • Day's H/L (Rs.) :
  • 668.00 - 640.00
  • 52wk H/L (Rs.) :
  • 839.95 - 277.95
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - Venus Remedies Ltd.
PE Ratios
17.22
EPS (Rs.)
39.30
Sales (Rs. Cr)
179.95
Face Value (Rs.)
10
Net Profit Margin(%)
8.21
Last Bonus
-
Last Dividend(%)
30
Return on Average Equity
8.91

News for Venus Remedies Ltd.

Venus Remedies: Drugs Approved in Vietnam
Venus Remedies secures marketing authorisations for Methotrexate, Cefuroxime, Irinotecan in Vietnam. Expands export footprint in South Asia.
Nov 09, 2025 12:22
Venus Remedies Renews Ukrainian GMP Certification
Venus Remedies has renewed its GMP certification from Ukraine's State Service on Medicines and Drugs Control (SMDC), reinforcing its position in the Ukrainian market and expanding its reach into...
May 24, 2025 10:37
Venus Remedies Gets Marketing Nod for Sugammadex in Philippines
Venus Remedies receives marketing authorisation for Sugammadex in the Philippines, marking a major step in its expansion into complex generics and the ASEAN market. Sugammadex is a relaxant-binding...
Mar 04, 2025 13:05
Venus Remedies Partners with UK Firm to Develop MET-X for Drug-Resistant Infections
Venus Remedies has partnered with Infex Therapeutics to develop MET-X, an innovative metallo-beta-lactamase inhibitor, to tackle drug-resistant gram-negative bacteria in India. The partnership aims...
Feb 25, 2025 12:18
Venus Remedies Secures Market Authorization for Anticoagulant in Indonesia
Venus Remedies has received marketing authorization from Indonesia for its Enoxaparin, an anticoagulant, in pre-filled syringes. The approval reinforces the company's presence in Southeast Asia and...
Feb 10, 2025 18:06

More News for Venus Remedies Ltd. »

News for Pharmaceuticals and health care

India Industrial Output Slows to 4.8% in January
India''s industrial production growth decelerated to 4.8% in January, a three-month low, due to mining & manufacturing slowdown.
Mar 02, 2026 16:23
Gateway Dehradun Opens in Uttarakhand
IHCL launches 100-key Gateway Dehradun, marking the Gateway brand's debut in Uttarakhand. A new leisure and business hub.
Mar 02, 2026 16:13
Rupee Crashes to 91.50 Amid US-Iran Tensions
Rupee plunges 42 paise to 91.50 against USD amid US-Iran conflict, rising crude oil prices, and FII outflows. RBI intervention seen.
Mar 02, 2026 16:09
Gaurs Group Invests Rs 100 Cr in Precast Plant
Gaurs Group invests Rs 100 cr in Greater Noida precast plant. MoU with Elematic India to boost construction efficiency and reduce timelines.
Mar 02, 2026 16:09
Stock Market Meltdown: West Asia Crisis Intensifies
Sensex and Nifty tumble as West Asia tensions escalate, crude oil prices spike. FII outflows add to market woes. Get the latest market updates.
Mar 02, 2026 16:02

More News »

Top News

India, Canada Aim for USD 50 Billion Trade
India and Canada commit to boost bilateral trade to USD 50 billion by 2030. Focus on CEPA, economic growth, and infrastructure development.
Mar 02, 2026 16:26
Raajmarg Infra InvIT IPO Opens March 11
NHAI-backed Raajmarg Infra Investment Trust (RIIT) launches its Rs 6,000 crore IPO on March 11. Details on anchor investors and more.
Mar 02, 2026 16:25
India Industrial Output Slows to 4.8% in January
India''s industrial production growth decelerated to 4.8% in January, a three-month low, due to mining & manufacturing slowdown.
Mar 02, 2026 16:23
Gateway Dehradun Opens in Uttarakhand
IHCL launches 100-key Gateway Dehradun, marking the Gateway brand's debut in Uttarakhand. A new leisure and business hub.
Mar 02, 2026 16:13
Rupee Crashes to 91.50 Amid US-Iran Tensions
Rupee plunges 42 paise to 91.50 against USD amid US-Iran conflict, rising crude oil prices, and FII outflows. RBI intervention seen.
Mar 02, 2026 16:09

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com